Form 4: FactSet Legal Officer Acquires Stock Options

FactSet's Chief Legal Officer, Christopher McLoughlin, acquired 5,310 employee stock options with an exercise price of $264.57, vesting over four years.

Summary

• Christopher McLoughlin, Chief Legal Officer of FactSet Research Systems Inc. (FDS), acquired 5,310 employee stock options.
• The options have an exercise price of $264.57 per share.
• The grant date for these options was November 3, 2025.
• The options vest 25% annually on the anniversary of the grant date and will be fully vested after four years.
• The options expire on November 3, 2035.
• This transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a key executive is generally a positive signal, aligning management's interests with shareholders. The 10b5-1 plan indicates a pre-planned transaction, reducing concerns about opportunistic timing. It's a standard compensation event, not a major market-moving announcement.

Positives

• The acquisition of stock options by a key executive aligns management's interests with shareholder value.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary transaction.

Risks

• The value of the stock options is dependent on the future performance of FactSet's common stock.
• If the stock price does not exceed the exercise price of $264.57, the options may not be profitable.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the vesting and expiration dates of the options.

Industry Context

Insider option grants are a standard component of executive compensation packages across various industries, including financial data and analytics. This aligns with common practices to incentivize long-term performance.

Comparison to Industry Standards

• The grant of stock options to a Chief Legal Officer is a common practice in publicly traded companies, including peers in the financial data and analytics sector like S&P Global (SPGI) or MSCI (MSCI), to align executive incentives with shareholder interests.
• The vesting schedule of 25% annually over four years is a standard industry practice for equity compensation, promoting executive retention and long-term focus.

Related Party Transactions

• The stock option grant is a form of compensation from the company to an executive, which is a related party transaction, but it is standard and disclosed.

Stakeholder Impact

• Shareholders: Potential positive impact as executive compensation is aligned with stock performance, incentivizing long-term growth.
• Employees: No direct impact on general employees, but it reflects the company's executive compensation structure.

Next Steps

• The options will vest annually at 25% on the anniversary of the grant date (November 3rd) for the next four years.
• Christopher McLoughlin may exercise these options at any time after they vest and before their expiration date of November 3, 2035.

Key Dates

Recommendation

This Form 4 reports a routine grant of employee stock options to a key executive under a pre-planned 10b5-1 arrangement. While it aligns executive incentives with shareholder interests, it does not provide new fundamental information about the company's financial performance, strategic direction, or market position that would warrant a change in investment recommendation. It's a standard compensation event.

Keywords

FactSet Research Systems, FDS, Stock Options, Insider Trading, Executive Compensation, Form 4, McLoughlin Christopher, Chief Legal Officer